Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Bumrungrad Hospital PCL's Price-to-Tangible-Book or its related term are showing as below:
BUGDF'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3.96 Med: 7.17 Max: 10.4
Current: 6.01
During the past 13 years, Bumrungrad Hospital PCL's highest Price to Tangible Book Ratio was 10.40. The lowest was 3.96. And the median was 7.17.
BUGDF's Price-to-Tangible-Book is ranked worse than 73.47% of 505
companies
in the Healthcare Providers & Services industry
Industry Median: 2.63
vs BUGDF: 6.01
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Bumrungrad Hospital PCL Price-to-Tangible-Book Related Terms
Bumrungrad Hospital PCL Price-to-Tangible-Book Historical Data
* Premium members only.
The historical data trend for Bumrungrad Hospital PCL's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BUGDF vs HCA, THC, DVA: Price-to-Tangible-Book Comparison
For the Medical Care Facilities subindustry, Bumrungrad Hospital PCL's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bumrungrad Hospital PCL Price-to-Tangible-Book vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Bumrungrad Hospital PCL's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Bumrungrad Hospital PCL's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Bumrungrad Hospital PCL (BUGDF) has a Price-to-Tangible-Book of 4.68 as of Aug. 27, 2026. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Bumrungrad Hospital PCL and its competitors. According to the industry distribution chart, Bumrungrad Hospital PCL ranks #371 out of 505 companies in the Healthcare Providers & Services industry, placing it in the top 73.5%.
Is Bumrungrad Hospital PCL's Price-to-Tangible-Book too high?
Bumrungrad Hospital PCL's current Price-to-Tangible-Book is 4.68. The Healthcare Providers & Services industry median Price-to-Tangible-Book is 2.63. Bumrungrad Hospital PCL's value of 4.68 is 77.9% above this industry median. Based on the distribution chart, Bumrungrad Hospital PCL ranks #371 out of 505 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Bumrungrad Hospital PCL has a GF Score™ of 98/100, reflecting its overall financial health beyond just this single metric.
How does Bumrungrad Hospital PCL's Price-to-Tangible-Book compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Bumrungrad Hospital PCL ranks #371 out of 505 companies for Price-to-Tangible-Book. This places Bumrungrad Hospital PCL in the lower half of its industry. The industry median Price-to-Tangible-Book is 2.63. Bumrungrad Hospital PCL's value of 4.68 is 77.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Price-to-Tangible-Book for a Healthcare Providers & Services company?
The median Price-to-Tangible-Book among Healthcare Providers & Services companies is 2.63, based on 505 companies in the industry. Companies in the top quartile (top 25%) have a Price-to-Tangible-Book significantly above this median, while those in the bottom quartile fall well below. However, Price-to-Tangible-Book should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bumrungrad Hospital PCL's current Price-to-Tangible-Book of 4.68 is 77.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Price-to-Tangible-Book mean?
A high Price-to-Tangible-Book can signal that a stock is expensive relative to its fundamentals. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on Bumrungrad Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median Price-to-Tangible-Book is 2.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bumrungrad Hospital PCL's current Price-to-Tangible-Book is 4.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bumrungrad Hospital PCL stock overvalued right now?
Bumrungrad Hospital PCL (BUGDF) has a current Price-to-Tangible-Book of 4.68. The stock's GF Value™ is $4.57, compared to a current price of $4.75 — trading 3.9% above its estimated fair value. The current Price-to-Tangible-Book is 4.68 and 77.9% above the Healthcare Providers & Services industry median of 2.63. Bumrungrad Hospital PCL's overall GF Score™ is 98/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Price-to-Tangible-Book calculated?
Price-to-Tangible-Book is calculated from a company's financial statements. For Bumrungrad Hospital PCL (BUGDF), the current Price-to-Tangible-Book is 4.68 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bumrungrad Hospital PCL (BUGDF) Overvalued in 2026?
Based on GuruFocus' analysis, Bumrungrad Hospital PCL stock appears to be overvalued.
The current stock price of $4.75 is trading 3.9% above its estimated GF Value™ of $4.57.
Key valuation signals for BUGDF:
Price-to-Tangible-Book: 4.68
GF Value™: $4.57 vs. price of $4.75 (3.9% above fair value)
Industry Position: 77.9% above the Healthcare Providers & Services median (#371 of 505)
No single metric tells the full story. See the BUGDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bumrungrad Hospital PCL operates a private hospital business in Bangkok. The company operates several healthcare-related entities, within and outside of Thailand which include Bumrungrad International Hospital, Bumrungrad International Clinic, Vitallife Scientific Wellness Center, VitalLife Skin Clinic, Bumrungrad International Dialysis Clinic, and others. It is a healthcare provider in Thailand providing complete healthcare services for both outpatients and inpatients. The company is the owner and operator of multiple healthcare-related entities. The company has only one main reportable operating segment, which is the hospital and health care center business, and the geographical area of its operations is Thailand.
98GF Score
Get the complete analysis for BUGDF
Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BUGDF has been successfully added to your 
